All Relations between Fabry Disease and hypertrophic

Publication Sentence Publish Date Extraction Date Species
Wei-Wen Chen, Ling Kuo, Yi-Xun Lin, Wen-Chung Yu, Chien-Chao Tseng, Yenn-Jiang Lin, Ching-Chun Huang, Shih-Lin Chang, Jacky Chung-Hao Wu, Chun-Ku Chen, Ching-Yao Weng, Siwa Chan, Wei-Wen Lin, Yu-Cheng Hsieh, Ming-Chih Lin, Yun-Ching Fu, Tsung Chen, Shih-Ann Chen, Henry Horng-Shing L. A Deep Learning Approach to Classify Fabry Cardiomyopathy from Hypertrophic Cardiomyopathy Using Cine Imaging on Cardiac Magnetic Resonance. International journal of biomedical imaging. vol 2024. 2024-05-06. PMID:38706878. a challenge in accurately identifying and classifying left ventricular hypertrophy (lvh) is distinguishing it from hypertrophic cardiomyopathy (hcm) and fabry disease. 2024-05-06 2024-05-08 Not clear
Wei-Wen Chen, Ling Kuo, Yi-Xun Lin, Wen-Chung Yu, Chien-Chao Tseng, Yenn-Jiang Lin, Ching-Chun Huang, Shih-Lin Chang, Jacky Chung-Hao Wu, Chun-Ku Chen, Ching-Yao Weng, Siwa Chan, Wei-Wen Lin, Yu-Cheng Hsieh, Ming-Chih Lin, Yun-Ching Fu, Tsung Chen, Shih-Ann Chen, Henry Horng-Shing L. A Deep Learning Approach to Classify Fabry Cardiomyopathy from Hypertrophic Cardiomyopathy Using Cine Imaging on Cardiac Magnetic Resonance. International journal of biomedical imaging. vol 2024. 2024-05-06. PMID:38706878. our proposed system named the mri short-axis view left ventricular hypertrophy classifier (mslvhc) is a high-accuracy standardized imaging classification model developed using ai and trained on mri short-axis (sax) view cine images to distinguish between hcm and fabry disease. 2024-05-06 2024-05-08 Not clear
Hao-Chih Chang, Ling Kuo, Shih-Hsien Sung, Dau-Ming Niu, Wen-Chung Y. Prognostic implications of left ventricular hypertrophy and mechanical function in Fabry disease: A longitudinal cohort study. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2024-05-04. PMID:38704103. prognostic implications of left ventricular hypertrophy and mechanical function in fabry disease: a longitudinal cohort study. 2024-05-04 2024-05-07 Not clear
Hao-Chih Chang, Ling Kuo, Shih-Hsien Sung, Dau-Ming Niu, Wen-Chung Y. Prognostic implications of left ventricular hypertrophy and mechanical function in Fabry disease: A longitudinal cohort study. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2024-05-04. PMID:38704103. the prognostic value of different grades of left ventricular hypertrophy (lvh) and left ventricular (lv) mechanical function in fabry disease is unclear. 2024-05-04 2024-05-07 Not clear
Emanuele Monda, Athanasios Bakalakos, Robin Lachmann, Petros Syrris, Giuseppe Limongelli, Elaine Murphy, Derralynn Hughes, Perry Mark Elliot. Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease. Heart (British Cardiac Society). 2024-04-30. PMID:38688703. incidence and risk factors for development of left ventricular hypertrophy in fabry disease. 2024-04-30 2024-05-03 Not clear
Emanuele Monda, Athanasios Bakalakos, Robin Lachmann, Petros Syrris, Giuseppe Limongelli, Elaine Murphy, Derralynn Hughes, Perry Mark Elliot. Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease. Heart (British Cardiac Society). 2024-04-30. PMID:38688703. left ventricular hypertrophy (lvh) is the principal cardiac manifestation of fabry disease (fd). 2024-04-30 2024-05-03 Not clear
Maria Chiara Meucci, Rosa Lillo, Federica Mango, Mario Marsilia, Giulia Iannaccone, Filippo Tusa, Marco Luigetti, Elena Biagini, Massimo Massetti, Gaetano Antonio Lanza, Antonella Lombardo, Francesca Grazian. Left atrial structural and functional remodelling in Fabry disease and cardiac amyloidosis: A comparative analysis. International journal of cardiology. 2024-02-21. PMID:38382852. fabry disease (fd) and transthyretin cardiac amyloidosis (ttr ca) are cardiomyopathies with hypertrophic phenotype that share several features, including left atrial (la) enlargement and dysfunction, but direct comparative data are lacking. 2024-02-21 2024-02-24 Not clear
Onur Akhan, Mehmet Kış, Tuncay Güzel, Mehdi Zogh. Differences Between Two Distinct Hypertrophic Cardiac Conditions: Fabry Disease versus Hypertrophic Cardiomyopathy. Arquivos brasileiros de cardiologia. vol 121. issue 1. 2024-02-07. PMID:38324858. differences between two distinct hypertrophic cardiac conditions: fabry disease versus hypertrophic cardiomyopathy. 2024-02-07 2024-02-10 Not clear
Onur Akhan, Mehmet Kış, Tuncay Güzel, Mehdi Zogh. Differences Between Two Distinct Hypertrophic Cardiac Conditions: Fabry Disease versus Hypertrophic Cardiomyopathy. Arquivos brasileiros de cardiologia. vol 121. issue 1. 2024-02-07. PMID:38324858. hypertrophic cardiomyopathy (hcm) and fabry disease (fd) are genetically inherited diseases with left ventricular hypertrophy (lvh) phenotype characteristics that cause adverse cardiac outcomes. 2024-02-07 2024-02-10 Not clear
Fu-Pang Chang, Ting-Rong Hsu, Sheng-Che Hung, Shih-Hsien Sung, Wen-Chung Yu, Dau-Ming Niu, Behzad Najafia. Cardiomyocyte Globotriaosylceramide Accumulation in Adult Male Patients with Fabry Disease and IVS4 + 919G>A GLA Mutation is Progressive with Age and Correlates with Left Ventricular Hypertrophy and Reduced Left Ventricular Ejection Fraction. medRxiv : the preprint server for health sciences. 2024-01-03. PMID:38168318. cardiomyocyte globotriaosylceramide accumulation in adult male patients with fabry disease and ivs4 + 919g>a gla mutation is progressive with age and correlates with left ventricular hypertrophy and reduced left ventricular ejection fraction. 2024-01-03 2024-01-06 Not clear
Fu-Pang Chang, Ting-Rong Hsu, Sheng-Che Hung, Shih-Hsien Sung, Wen-Chung Yu, Dau-Ming Niu, Behzad Najafia. Cardiomyocyte Globotriaosylceramide Accumulation in Adult Male Patients with Fabry Disease and IVS4 + 919G>A GLA Mutation is Progressive with Age and Correlates with Left Ventricular Hypertrophy and Reduced Left Ventricular Ejection Fraction. medRxiv : the preprint server for health sciences. 2024-01-03. PMID:38168318. while cardiovascular complications are the most common cause of mortality in fabry disease, the relationship between globotriaosylceramide (gl-3) accumulation, the hallmark of fabry cardiomyopathy, and cardiac hypertrophy has not been fully elucidated. 2024-01-03 2024-01-06 Not clear
Isabel Mattig, Tilman Steudel, Gina Barzen, David Frumkin, Sebastian Spethmann, Elena Romero Dorta, Karl Stangl, Bettina Heidecker, Ulf Landmesser, Fabian Knebel, Sima Canaan-Kühl, Katrin Hahn, Anna Bran. Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry disease. International journal of cardiology. 2023-12-04. PMID:38048880. diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and fabry disease. 2023-12-04 2023-12-10 Not clear
Kamil Stankowski, Stefano Figliozzi, Vincenzo Battaglia, Federica Catapano, Marco Francone, Lorenzo Mont. Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy. Journal of clinical medicine. vol 12. issue 22. 2023-11-25. PMID:38002674. fabry disease: more than a phenocopy of hypertrophic cardiomyopathy. 2023-11-25 2023-11-28 Not clear
Maomao Zhao, Xiaowei Niu, Lu Bai, Yinchang Zhang, Ting Wang, Yongling Wa, Junchu Wei, Kang Dong, Xin Zhang, Ming Ba. Unexplained Left Ventricular Hypertrophy Diagnosed as a Cardiac Variant of Late-Onset Fabry Disease: A Case Report. Journal of cardiovascular development and disease. vol 10. issue 9. 2023-09-27. PMID:37754818. unexplained left ventricular hypertrophy diagnosed as a cardiac variant of late-onset fabry disease: a case report. 2023-09-27 2023-10-07 Not clear
Andrea Frustaci, Valentino Borghetti, Samuele Pentiricci, Romina Verardo, Rossella Scialla, Matteo Antonio Russ. Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy. ESC heart failure. 2023-09-16. PMID:37715354. hypertrophic obstructive cardiomyopathy caused by fabry disease: implications for surgical myectomy. 2023-09-16 2023-10-07 Not clear
Andrea Frustaci, Valentino Borghetti, Samuele Pentiricci, Romina Verardo, Rossella Scialla, Matteo Antonio Russ. Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy. ESC heart failure. 2023-09-16. PMID:37715354. hypertrophic obstructive cardiomyopathy can be the phenotype of storage disorders as fabry disease cardiomyopathy. 2023-09-16 2023-10-07 Not clear
Alice Moroni, Lara Tondi, Valentina Milani, Maurizio Pieroni, Federico Pieruzzi, Francesca Bevilacqua, Giulia Pasqualin, Kelvin Chow, Silvia Pica, Massimo Lombardi, Antonia Camporeal. Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis. International journal of cardiology. 2023-09-11. PMID:37696360. left atrial remodeling in hypertrophic cardiomyopathy and fabry disease: a cmr-based head-to-head comparison and outcome analysis. 2023-09-11 2023-10-07 Not clear
Alice Moroni, Lara Tondi, Valentina Milani, Maurizio Pieroni, Federico Pieruzzi, Francesca Bevilacqua, Giulia Pasqualin, Kelvin Chow, Silvia Pica, Massimo Lombardi, Antonia Camporeal. Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis. International journal of cardiology. 2023-09-11. PMID:37696360. hypertrophic cardiomyopathy (hcm) and fabry disease cardiomyopathy (fd) are phenocopies, as they show left ventricular hypertrophy (lvh). 2023-09-11 2023-10-07 Not clear
Anna Burban, Szymon Pucyło, Aleksandra Sikora, Grzegorz Opolski, Marcin Grabowski, Agnieszka Kołodzińsk. Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement. International journal of molecular sciences. vol 24. issue 17. 2023-09-09. PMID:37686045. this article focuses on hcm and other cardiomyopathies with myocardial hypertrophy, including fabry disease, pompe disease, and danon disease. 2023-09-09 2023-10-07 Not clear
Tomás Francisco Cianciulli, María Cristina Saccheri, Mariano Napoli Llobera, Lorena Romina Balletti, Matín Alejandro Beck, Luis Alberto Morita, Jorge Alberto La. Prevalence of papillary muscle hypertrophy in fabry disease. BMC cardiovascular disorders. vol 23. issue 1. 2023-08-27. PMID:37635225. prevalence of papillary muscle hypertrophy in fabry disease. 2023-08-27 2023-09-07 Not clear